4 MG-ADL–based response rates in our real-world cohorts were considerably lower, and clinical efficacy assessed by the physician-reported QMG scale did not reach statistical significance in either treatment group after 4, 8, and 10 weeks.
1
—
—
4 MG-ADL–based response rates in our real-world cohorts were considerably lower, and clinical efficacy assessed by the physician-reported QMG scale did not reach statistical significance in either treatment group after 4, 8, and 10 weeks.